Impact of the COVID-19 pandemic on testing services for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region, March to August 2020

We present preliminary results of a coronavirus disease (COVID-19) impact assessment on testing for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region. We analyse 98 responses from secondary care (n = 36), community testing sites (n = 52) and national level (n = 10)....

Descripción completa

Detalles Bibliográficos
Autores principales: Simões, Daniel, Stengaard, Annemarie Rinder, Combs, Lauren, Raben, Dorthe, Pharris, Anastasia, Winter, Andrew, Sullivan, Ann K, von Lingen, Ann-Isabelle, Mozalevskis, Antons, James, Cary, Rokx, Casper, Agusti, Cristina, Alexeeva, Daria, Vovc, Elena, Duffel, Erika, Kuchukhidze, Giorgi, Casabona, Jordi, Rockstroh, Jürgen K, Kowalska, Justyna D, Rüütel, Kristi, Tavoschi, Lara, Fernandez-Lopez, Laura, Unemo, Magnus, Buti, Maria, Krone, Michael, Seguy, Nicole, Mardh, Otilia, Ehsani, Soudeh, Noori, Teymur, Delpech, Valerie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2020
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693166/
https://www.ncbi.nlm.nih.gov/pubmed/33243354
http://dx.doi.org/10.2807/1560-7917.ES.2020.25.47.2001943
Descripción
Sumario:We present preliminary results of a coronavirus disease (COVID-19) impact assessment on testing for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region. We analyse 98 responses from secondary care (n = 36), community testing sites (n = 52) and national level (n = 10). Compared to pre-COVID-19, 95% of respondents report decreased testing volumes during March–May and 58% during June–August 2020. Reasons for decreases and mitigation measures were analysed.

Ejemplares similares